Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study
尼尔马特雷韦-利托那韦(Paxlovid)治疗发病超过5天的COVID-19患者的真实世界疗效和安全性:一项回顾性队列研究
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1401658
Qiu, Ye; Wen, Hao; Wang, Haoru; Sun, Wenjun; Li, Guangchao; Li, Shaoqiang; Wang, Yan; Zhai, Jingnan; Zhan, Yangqing; Su, Yutian; Long, Zhiwei; Li, Zhengtu; Ye, Feng